916578-53-5

Basic information

• Product Name: tert-butyl 4-(chloromethyl)phenylcarbamate
• Synonyms: tert-butyl 4-(chloromethyl)phenylcarbamate
• CAS NO: 916578-53-5
• Molecular Formula: C₁₂H₁₆ClNO₂
• Molecular Weight: 241.71394
• Mol File: 916578-53-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(chloromethyl)phenylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(chloromethyl)phenylcarbamate(916578-53-5)
• EPA Substance Registry System: tert-butyl 4-(chloromethyl)phenylcarbamate(916578-53-5)

Safety Data

• Hazardous Substances Data: 916578-53-5(Hazardous Substances Data)

Upstream product

• 623-04-1 4-aminobenzenemethanol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 
• 144072-29-7 tert-butyl N-[4-(hydroxymethyl)phenyl]carbamate 

Downstream Products

• 866005-62-1 (4-isothiocyanatomethyl-phenyl)-carbamic acid tert-butyl ester 
• 1346771-64-9 C₁₇H₂₃N₃O₄S 
• 1346771-63-8 C₁₈H₂₃N₃O₄S 
• 1346771-62-7 C₁₇H₂₂ClN₃O₄S 
• 1346771-61-6 C₁₇H₂₂BrN₃O₄S 
• 220298-96-4 4‐(tert‐butoxycarbonylamino)benzylamine 
• 916578-51-3 2-(4-t-butylalcoholcarbonylaminophenyl)methyl-3,4-dihydro-6,7-dimethoxy-1-undecylisoquinolinium chloride 

Relevant articles and documents

Methanesulfinylation of Benzyl Halides with Dimethyl Sulfoxide

A phenyltrimethylammonium tribromide-mediated nucleophilic substitution/oxygen transformation reaction of benzyl halides with DMSO has been developed. In this transition-metal-free reaction, DMSO acts as not only a solvent but also a "S(O)Me" source, thus providing a convenient method for the efficient and direct synthesis of various benzyl methyl sulfoxides.

Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture

4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) was previously identified as an antileukemic agent exhibiting no evident toxicity toward normal hematopoietic cells. An SAR study has been carried out to examine the effect of varying the C-2 and

ORGANIC COMPOUNDS

The present invention provides heterocyclic derivatives that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.